期刊文献+

多西紫杉醇联合氟脲嘧啶及亚叶酸钙治疗晚期胃癌49例临床分析 被引量:1

The Clinical Study of Docetaxel Combined with Fluorouracil and Calcium Folinate for 49 Patients with Advanced Gastric Cancer
暂未订购
导出
摘要 目的观察多西紫杉醇联合氟脲嘧啶及亚叶酸钙治疗晚期胃癌的疗效和毒副反应。方法 49例晚期胃癌采用多西紫杉醇联合氟脲嘧啶及亚叶酸钙方案治疗,治疗后评价疗效和毒副反应。结果 49例均可评价疗效,其中CR3例,PR22例,SD11例,PD13例,总有效率为51.0%,中位疾病进展时间为5.5个月,中位生存期为9.3个月。毒副反应主要是骨髓抑制,其次为脱发、胃肠道反应、口腔黏膜炎、周围神经毒性。结论多西紫杉醇联合氟脲嘧啶及亚叶酸钙方案治疗晚期胃癌的疗效较好,毒副反应相对较低。 Objective To evaluate the efficacy and toxicities of the regimen of docetaxel combined with fluorouracil and calcium folinate in the treatment of patients with advanced gastric cancer.Methods Forty nine patients with advanced gastric cancer had been treated with the regimen of docetaxel combined with fluorouracil and calcium folinate.The efficacy and toxicities were evaluated.Results All the 49 cases were evaluable.Among them,3 cases achieved CR,22 cases PR,11 cases SD,13 cases PD.The overall response rate was 51.0%.Median time to progression was 5.5 months and median survival time was 9.3 months.The major toxicities were myelosuppression and alopecia,followed by gastrointestinal reaction,dental ulcer and perineural toxicity.Conclusion The regimen of docetaxel combined with fluorouracil and calcium folinate is effective for advanced gastric cancer and its toxicities are tolerable.
出处 《肿瘤基础与临床》 2010年第4期301-302,共2页 journal of basic and clinical oncology
关键词 晚期胃癌 多西紫杉醇 氟脲嘧啶 亚叶酸钙 化疗 advanced gastric cancer docetaxel fluorouracil calcium folinate chemotherapy
  • 相关文献

参考文献7

二级参考文献28

  • 1钱军,秦叔逵,梅静峰,陈映霞,邵志坚,何泽明.奥沙利铂联合卡培他滨二线治疗晚期胃癌的临床观察[J].中华肿瘤杂志,2004,26(12):746-748. 被引量:60
  • 2Comis R. Integration of chemotherapy into combined modality treatment of solid tumors[J]. Cancer Treat Rev, 1974,1:221.
  • 3Sulkes A, Smyth J ,Sessa C, et al.. Docetaxel(Taxotere) in advanced gastric cancer:results of a phase II clinical trial[J]. Br J Cancer ,1994,70(2):380~387.
  • 4Mavroudis D , Kourousis C ,Androulakis N , et al . Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF): a phase II trial [J] .Am J Clin Oncol ,2000,23(4):341~352.
  • 5Mai M , Sakata Y , Kanamaru R ,et al. A late phase II clinical study of RP56976 (docetaxel) in patients with advanced or recurrent gastric cancer: a cooperative study group trial (group B) [J].Gan To Kagaku Ryoho ,1999,26(4):487~495.
  • 6Roth AD , Maibac R , Martinelli G, et al . Docetaxel(Taxotere)-cisplatin(TC): an effective drug combination in gastric carcinoma [J] . Ann Oncol ,2000,11(3):301~311.
  • 7Yoshida K , Toge T .Combination chemotherapy of TS-1 and docetaxel on advanced and recurrent gastric cancer [J]. Gan To Kagaku Ryoho ,2004, 31(12):1982~1986.
  • 8Lewis VO,Primus G,Anastasi J,et al.Oncologic outcomes of primary lymphoma of bone in adults[J].Clinical Orthopaedics and Related Research,2003,415:90-97.
  • 9Ajani J A.Docetaxel fox gastric and esophageal carcinomas[J].Oncology(Huntingt),2002,6(2):89-96.
  • 10Ridwelski K,Gebauer T,Fahlke J,et al.Combination chemotherapy with docetaxel and cisplatin for locally advanced and metastatic gastric cancer[J].Ann Oncol,2001,12(1):47-51.

共引文献285

同被引文献3

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部